Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility

Molecular Cancer

Volumn 8, Issue , 2009, Pages

  Pecorari, Luisa ^a   Marin, Oriano ^b   Silvestri, Chiara ^a   Candini, Olivia ^a   Rossi, Elena ^a   Guerzoni, Clara ^a   Cattelani, Sara ^a   Mariani, Samanta A ^a   Corradini, Francesca ^a   Ferrari Amorotti, Giovanna ^a   Cortesi, Laura ^a   Bussolari, Rita ^a   Raschellà, Giuseppe ^c   Federico, Massimo R ^a   Calabretta, Bruno ^a,d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c ENEA C R CASACCIA   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 1ALPHA; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN KINASE B INHIBITOR; SMALL INTERFERING RNA; ELONGATION FACTOR 1;

ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; BREAST TUMOR; CELL CYCLE; CELL MOTION; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; PEPTIDE ELONGATION FACTOR 1; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE;

EID: 68949217138     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-58     Document Type: Article

References (34)

1. Watters JW Roberts CJ Developing gene expression signatures of pathway deregulation in tumors Mol Cancer Ther 2006, 5:2444-2449. 10.1158/ 1535-7163.MCT-06-0340 17041087
2. Vivanco I Sawyers CL The phosphatidylinositol 3-Kinase AKT pathway in human cancer Nat Rev Cancer 2002, 2:489-501. 10.1038/nrc839 12094235
3. Samuels Y Whang Z Bardelli A Silliman N Ptak J Szabo S Yan H Gazdar A Powell SM Riggins GJ Willson JK Markowitz S Kinzler KW Vogelstein B Velculescu VE High frequency of mutations of the PIK3CA in human cancers Science 2004, 304:554-560. 10.1126/science.1096502 15016963
4. Cantley LC Neel BG New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway Proc Natl Acad Sci USA 1999, 96:4240-4245. 10.1073/pnas.96.8.4240 33561 10200246
5. Carpten JD Faber AL Horn C Donoho GP Briggs SL Robbins CM Hostetter G Boguslawski S Moses TY Savage S Uhlik M Lin A Du J Qian YW Zeckner DJ Tucker-Kellogg G Touchman J Patel K Mousses S Bittner M Schevitz R Lai MH Blanchard KL Thomas JE A transforming mutation in the pleckstrin homology domain of Akt1 in cancer Nature 2007, 448:439-444. 10.1038/ nature05933 17611497
6. Liu W Bagaitkar J Watabe K Roles of AKT signal in breast cancer Front Biosci 2007, 12:4011-9. 10.2741/2367 17485354
7. Bellacosa A Kumar CC Cristofano AD Testa JR Activation of Akt kinases in cancer: Implications for therapeutic targeting Adv Cancer Res 2005, 94:29-86. 10.1016/S0065-230X(05)94002-5 16095999
8. Sutherland BW Kucab J Wu J Lee C Cheang MC Yorida E Turbin D Dedhar S Nelson C Pollak M Leighton Grimes H Miller K Badve S Huntsman D Blake-Gilks C Chen M Pallen CJ Dunn SE Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells Oncogene 2005, 16:4281-92. 10.1038/sj.onc.1208590
9. Barnett SF Defeo-Jones D Fu S Hancock PJ Haskell KM Jones RE Kahana JA Kral AM Leander K Lee LL Malinowski J McAvoy EM Nahas DD Robinson RG Huber HE Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors Biochem J 2005, 15:399-408.
10. DeFeo-Jones D Barnett SF Fu S Hancock PJ Haskell KM Leander KR McAvoy E Robinson RG Duggan ME Lindsley CW Zhao Z Huber HE Jones RE Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members Mol Cancer Ther 2005, 4:271-279. 15713898
11. Irie HY Pearline RV Grueneberg D Hsia M Ravichandran P Kothari N Natesan S Brugge JS Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition J Cell Biol 2005, 171:1023-34. 10.1083/jcb.200505087 2171329 16365168
12. Toker A Yoeli-Lerner M Akt signaling and cancer: Surviving but not moving on Cancer Res 2006, 66:3963-3966. 10.1158/0008-5472.CAN-06-0743 16618711
13. Browne GJ Proud CG Regulation of peptide-chain elongation in mammalian cells Eur J Biochem 2002, 269:5360-5368. 10.1046/ j.1432-1033.2002.03290.x 12423334
14. Knudsen SM Frydenberg J Clark BF Leffers H (Tissue-dependent variation in the expression of elongation factor 1 alpha isoforms: Isolation and characterisation of a cDNA encoding a novel variant of human elongation factor 1 alpha Eur J Biochem 1993, 215:549-554. 10.1111/ j.1432-1033.1993.tb18064.x 8354261
15. Lee JM The role of protein elongation factor EF1A2 in ovarian cancer Reprod Biol Endocrinol 2003, 1:69-73. 10.1186/1477-7827-1-69 239897 14588074
16. Edmonds BT Wyckoff J Yeung YG Wang Y Stanley ER Jones J Segall J Condeelis J Elongation factor -1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma J Cell Sci 1996, 109:2705-2714. 8937988
17. Tomlinson VA Newbery HJ Wray NR Jackson J Larionov A Miller WR Dixon JM Abbott CM Translation elongation factor EF1a2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours BMC Cancer 2005, 5:113. 10.1186/1471-2407-5-113 1236916 16156888
18. Kulkarni G Turbin DA Amiri A Jeganathan S Andrade-Navarro MA Wu TD Huntsman DG Lee JM Expression of protein elongation factor EF1A2 predicts favorable outcome in breast cancer Breast Cancer Res Treat 2007, 102:31-34. 10.1007/s10549-006-9315-8 16897428
19. Amiri A Noei F Jeganathan S Kulkarni G Pinke DE Lee JM EF1A2 activates Akt and stimulates Akt dependent actin remodelling, invasion and migration Oncogene 2007, 26:3027-40. 10.1038/sj.onc.1210101 17130842
20. Vanhaesebroek B Alessi DR The PI3K-PDK1 connection: More than just a road to PKB Biochem J 2000, 346:561-576. 10.1042/0264-6021:3460561 1220886 10698680
21. Bhaskar PT Hay N The two TORCs and AKT Dev Cell 2007, 12:487-502. 10.1016/j.devcel.2007.03.020 17419990
22. Yang F Demma M Warren V Dharmawardhane S Condeelis J Identification of an actin-binding protein from Dictyostelium as elongation factor 1a Nature 1990, 347:494-6. 10.1038/347494a0 2215665
23. Condeelis J Elongation factor 1 alpha, translation and the cytoskeleton Trends Biochem Sci 1995, 20:169-70. 10.1016/S0968-0004(00)88998-7 7610475
24. Yoeli-Lerner M Yiu GK Rabinovitz I Erhardt P Jauliac S Toker A Akt Blocks Breast Cancer Cell Motility and Invasion through the Transcription Factor NFAT Mol Cell 2005, 20:539-550. 10.1016/ j.molcel.2005.10.033 16307918
25. Lau J Castelli LA Lin ECK Macaulay SL Identification of elongation factor 1 alpha as a potential associated binding partner for Akt2 Mol Cell Biochem 2006, 286:17-22. 10.1007/s11010-005-9006-5 16652225
26. Bacus SS Altomare DA Lyass L Chin DM Farrell MP Gurova K Gudkov A Testa JR AKT2 is frequently upregulated in Her-2/neu-positive breast cancer and may contribute to tumor aggressiveness by enhancing cell survival Oncogene 2002, 21:3532-40. 10.1038/sj.onc.1205438 12032855
27. Yoeli-Lerner M Toker A Akt/PKB signaling in cancer: A function in cell motility and invasion Cell Cycle 2006, 5:603-605. 16582622
28. Thornton S Anand N Purcell D Lee J Not just for housekeeping: Protein initiation and elongation factors in cell growth and tumorigenesis J Mol Med 2003, 81:536-548. 10.1007/s00109-003-0461-8 12898041
29. Pencil SD Toh Y Nicolson GL Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma Breast Cancer Res Treat 1993, 25:165-7. 10.1007/BF00662141 8347848
30. Liu H Radisky DC Nelson CM Zhang H Fata JE Roth RA Bissel MJ Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2 Proc Natl Acad Sci USA 2006, 103:4134-4139. 10.1073/pnas.0511342103 1390746,1390746 16537497
31. Grille SJ Bellacosa A Upson J Klein-Szanto AJ van Roy F Lee-Kwon W Donowitz M Tsichlis PN Larue L The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines Cancer Res 2003, 63:2172-8. 12727836
32. Diehl JA Cheng M Roussel MF Sherr CJ Glycogen synthase-3b regulates cyclin D1 proteolysis and subcellular localization Genes Dev 1998, 12:3499-3511. 10.1101/gad.12.22.3499 317244 9832503
33. Shin I Yakes FM Rojo F Shin NY Bakin AV Baselga J Arteaga CL PKB/Akt mediates cell-cycle progression by phosphorylation of p27 Kip1 at threonine 157 and modulation of its cellular localization Nature Medicine 2002, 8:1145-1151. 10.1038/nm759 12244301
34. Ruzzene M Pinna LA Assay of protein kinases and phosphatases using specific peptide substrates Protein Phosphorylation - A Practical Approach Oxford: Oxford University Press Hardie DG 1999:221-253.